Boldenone-induced apoptotic, structural, and functional alterations in the liver of rabbits

R.F. Mayada, M.S. Taghred, A.A. Haytham

Abstract

Boldenone undecylenate (BOL) is an anabolic androgenic steroid used in livestock to improve growth and food conversion. This study investigated the actions of BOL on structure and functions of rabbit liver as well as the effects of its withdrawal. Eighteen mature male New Zealand rabbits were divided into 2 groups: Control group (n=6) were injected with 0.25 mL corn oil/kg body weight (BW), while BOL group (n=12) received 3 intramuscular injections, 2 wk apart, of BOL (4.5 mg/kg BW). Animals were scarified 1 d after last injection except for 6 rabbits from BOL group that served as the BOL-withdrawal group (4 wk after the 3rd injection). Intramuscular injection of BOL increased (P<0.05) malondialdehyde (MDA) level, but markedly lowered activities of superoxide dismutase (SOD) and catalase (CAT) and reduced glutathione (GSH) concentration compared to both control and BOL-withdrawal groups. Treatment with BOL significantly (P<0.05) increased serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) compared to the control group. BOL injection caused different histopathological alterations and apoptosis in liver, but these changes were less evident in the BOL-withdrawal group. Expression of p53 and tumour necrosis factor-α (TNF-α) genes was up regulated in BOL compared to control group, while the expressions of p53 and TNF-α were down regulated in BOL-withdrawal group in comparison with BOL group. In conclusion, BOL injection induced structural and functional changes in the liver of rabbits, increasing oxidative stress and mediators of apoptosis such as ROS, p53 and TNF-α. All these parameters returned to near the control values after withdrawal.


Keywords

boldenone; liver; oxidative stress; apoptosis; rabbits

Full Text:

PDF

References

Amsterdam J., Opperhuizen A., Hartgens F. 2010. Adverse health effects of anabolic-androgenic steroids. Reg. Toxicol. Pharm., 57: 117-123. doi:10.1016/j.yrtph.2010.02.001

Ashkenazi A., Dixit V.M. 1998. Death receptors: signaling and modulation. Science, 281: 1305-1308. doi:10.1126/science.281.5381.1305

Battista V., Combs J., Warne W.J. 2003. Asynchronous bilateral Achilles tendon ruptures and rostenedioluse. Am. J. Sports Med., 31: 1007–1009.

Buzek J., Latonen L., Kurki S., Peltonen K., Laiho M. 2002. Redox state of tumor suppressor p53 regulates its sequence-specific DNA binding in DNA-damaged cells by cysteine 277. Nucleic Acids Res., 30: 2340-2348. doi:10.1093/nar/30.11.2340

Cannizzo T.F., Zancanaro G., Spada F., Mulasso C., Biolatti B. 2007. Pathology of the Testicle and Sex Accessory Glands Following the Administration of Boldenone and Boldione as Growth Promoters in Veal Calves. J. Vet. Med. Sci., 69: 1109-1116. doi:10.1292/jvms.69.1109

Du Toit E.F., Rossouw E., Van Rooyen J., Lochner A. 2005. Proposed mechanisms for the anabolic steroid-induced increase in myocardial susceptibility to ischemia/reperfusion injury. Cardiovasc. J. Afr., 16: 21-28.

El-Moghazy M., Tousson E., Sakeran M.I. 2012. Changes in the hepatic and renal structure and function after a growth promoter boldenone injection in rabbits. Animal Biology, 62: 171-180.

Grawish M.E. 2008. Effects of Spirulina platensis extract on Syrian hamster cheek pouch mucosa painted with 7,12-dimethylbenz[a]anthracene. Oral Oncol., 44: 956-62. doi:10.1016/j.oraloncology.2007.11.014

Groot M.J., Biolatti B. 2004. Histopathological effects of boldenone in cattle. J. Vet. Med. A, 51: 58-63. doi:10.1111/j.1439-0442.2004.00606.x

Guan F., Uboh C.E., Soma L.R., You Y., Liu Y., Li X. 2010. High-throughput UHPLC MS/MS method for the detection, quantification and identification of fifty-five anabolicandrogenic steroids in equine plasma. J. Mass. Spectrom., 45:1270-1279. doi:10.1002/jms.1816

Hartgens F., Kuipers H. 2004. Effects of androgenic anabolicsteroids in athletes. Sports Medicine, 34: 513-554. doi:10.2165/00007256-200434080-00003

Kicman A.T. 2008. Pharmacology of anabolic steroids. Brit. J. Pharmacol., 154, 502-521. doi:10.1038/bjp.2008.165

Langfort J., Jagsz S., Dobrzyn P., Brzezinska Z., Kłapcińska B., Galbo H. 2010. Testosterone affects hormone-sensitive lipase (HSL) activity and lipid metabolism in the left ventricle. Biochemi. Bioph. Res. Co., 399: 670-676. doi:10.1016/j.bbrc.2010.07.140

Molano A.F., Saborido J., Delgado M., Megías A. 1999. Rat liver lysosomal and mitochondrial activities are modified by anabolic-androgenic steroids. Med. Sci. Sports Exerc., 31: 243-250. doi:10.1097/00005768-199902000-00007

Navarro C. M., Montilla P. M., Martín A., Jiménez J., Ultrilla P. M. 1993. Free radical scavenger and antihepatotoxic activity of Rosmarinus tomentosus. Planta Med., 59: 312-314. doi:10.1055/s-2006-959688

Paget G.E., Barnes J.M. 1964. Evaluation of drug activities, Toxicity Tests. Pharmacometrics, vol. I. London and New York: Academic Press, pp.135-166.

doi:10.1016/B978-1-4832-2845-7.50012-8

Peters R., Cooeland J., Dillon P., Beel A. 1997. Patterns and correlations of anabolic-androgenic steroid use. National Drug and Alcohol Research Centre, Technical Report number 48.

Rokhlin O.W., Gudkov A.V., Kwek S., Glover R.A., Gewies A.S., Cohen M.B. 2000. p53 is involved in tumor necrosis factor-α-induced apoptosis in the human prostatic carcinoma cell line LNCaP. Oncogene, 19: 1959-1968. doi:10.1038/sj.onc.1203453

Sadowska-Krepa E., Kłapcińska B., Jagsz S., Sobczak A., Chrapusta S.J., Chalimoniuk M., Grieb P., Proprzęcki. S., Langfort J. 2011. High-Dose Testosterone Propionate Treatment Reverses the Effects of Endurance Training on Myocardial Antioxidant Defenses in Adolescent Male Rats. Cardiovasc. Toxicol., 11: 118-127. doi:10.1007/s12012-011-9105-3

Soma L.R., Uboh C.E., Guan F., MC-Donnell S., Pack J. 2007. Pharmacokinetics of boldenone and stanozolol and the results of quantification of anabolic and androgenic steroids in race horses and nonrace horses. J. Vet. Pharmacol. Therapeut., 30: 101-108. doi:10.1111/j.1365-2885.2007.00824.x

Tousson E., Alm-Eldeen A., El-Moghazy M. 2011. p53 and Bcl-2 expression in response to boldenone induced liver cells injury. Toxicol. Ind. Health, 27: 711-718. doi:10.1177/0748233710395350

Tousson E., El-Moghazy M., Massoud A., El-Atrash E., Sweef O., Akel A. 2013. Physiological and biochemical changes after boldenone injection in adult rabbits. Toxicol. Ind. Health, doi:10.1177/0748233713501365.

Urhausen A., Torsten A., Kindermann W. 2003. Reversibility of the effects on blood cells, lipids liver function and hormones in former anabolic-androgenic steroid abusers. J. Steroid Biochem., 84: 369-375. doi:10.1016/S0960-0760(03)00105-5

Wang L., Bowman L., Lu Y., Rojanasakul Y., Mercer R.R., Castranova V., Ding M. 2005. Essential role of p53 in silicainduced apoptosis. Am. J. Physiol., 288: 488-496.

Welder A.A., Robertson J.W., Melchert R.B. 1995. Toxic effect of anabolic-androgenic steroids in primary rat hepatic cell cultures. J. Pharmacol. Toxicol., 33: 187-195. doi:10.1016/1056-8719(94)00073-D

Wong G., Vehar G., Kaspar R.L. 1997. Apoptosis and Cancer. Martin SJ (ed.) KargerLandes System, pp. 245-257.

Zaugg M., Jamali, N.Z., Lucchinetti E., Xu, W., Alam M., Shafiq S.A., Siddiqui M.A.Q. 2001. Anabolic-androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes. J. Cell. Physiol., 187: 90-95. doi:10.1002/1097-4652(2001)9999:9999<00::AID-JCP1057>3.0.CO;2-Y

Abstract Views

5604
Metrics Loading ...

Metrics powered by PLOS ALM




 Universitat Politècnica de València

Official journal of the World Rabbit Science Association (WRSA)

e-ISSN: 1989-8886     ISSN: 1257-5011  https://doi.org/10.4995/wrs